| Literature DB >> 35370814 |
Patryk Łakuta1,2.
Abstract
This study builds on growing evidence on implementation-intention-based self-affirmation intervention effects on mental health. Using a factorial design, this pre-registered study aimed to further investigate whether (1) strengthening the element of specificity within body-related self-affirming implementation intention (BS-AII) intervention compared to general self-affirming implementation intention (S-AII) would provide greater improvements in mental health outcomes for adults with psoriasis, and (2) whether the addition of a booster component would result in enhancing effectiveness at follow-up. A total of 306 adults with psoriasis were assessed for eligibility and 222 (aged 18-71 years) were randomized and received S-AII, BS-AII, or MGI (mere goal intention-control condition). Within each group, participants were again randomized to booster (B) or no-booster condition in a 3 × 2 factorial design, resulting in six groups: S-AII; S-AII + B; BS-AII; BS-AII + B; MGI; and MGI + B. Data were collected over three-time points, at baseline, 2 weeks post-intervention, and at 1-month later. Three primary outcomes were defined as a reduction of anxiety and depressive symptoms and enhancement of well-being. In terms of secondary outcomes, positive other- and self-directed feelings and also an emotional attitude toward the body were evaluated. To fully estimate intervention effects through intention-to-treat analysis, linear mixed models were used. A significant effect of time was observed, but no evidence of time-by-group interactions and no three-way interactions were detected. Exploratory analyses revealed two significant moderating effects of age and self-esteem, pointing to boundary conditions of the interventions. These findings offer to gain deeper insights on null (or negative) effects also reported in past works and highlight that self-affirmation interventions should be more thoroughly investigated and optimized before they can be broadly implemented in real-life contexts, especially to prevent backfiring and negative-enhancing effects.Entities:
Keywords: RCT—randomized controlled trial; factorial design; implementation intention; mental health; psoriasis; self-affirmation; well-being
Year: 2022 PMID: 35370814 PMCID: PMC8971365 DOI: 10.3389/fpsyt.2022.795055
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 1CONSORT flow diagram: enrollment, group randomization, attrition, and data analysis.
Baseline characteristics of the participants (N = 222).
|
|
|
|
| |
|---|---|---|---|---|
|
|
|
| ||
|
| ||||
| Age (years), | 31.77 (9.06) | 34.69 (10.64) | 35.12 (11.08) | |
| Gender, | ||||
| Female | 63 (85.1%) | 64 (86.5%) | 64 (86.5%) | |
| Male | 11 (14.9%) | 10 (13.5%) | 10 (13.5%) | |
| Marital status, | ||||
| Married/cohabiting | 55 (74.3%) | 56 (75.7%) | 49 (66.2%) | |
| Not married (single, divorced, widowed) | 19 (25.7%) | 18 (24.3%) | 25 (33.8%) | |
| Education level (highest level completed), | ||||
| Low (primary school, lower secondary) | 2 (2.7%) | 2 (2.7%) | 0 (0.0%) | |
| Intermediate (upper secondary education) | 30 (40.5%) | 27 (36.5%) | 32 (43.2%) | |
| High (tertiary education, university degree) | 42 (56.8%) | 45 (60.8%) | 42 (56.8%) | |
| Work status, | ||||
| Student | 10 (13.5%) | 6 (8.1%) | 8 (10.8%) | |
| Paid employment | 55 (74.3%) | 56 (75.7%) | 55 (74.3%) | |
| Unemployed | 9 (12.2%) | 7 (9.4%) | 7 (9.5%) | |
| Pensioner or retired | 0 (0.0%) | 5 (6.8%) | 4 (5.4%) | |
| Psoriasis severity (SAPASI), | 8.72 (7.96) | 9.01 (7.11) | 9.30 (6.62) | |
|
| ||||
| PHQ-9, | 10.55 (5.63) | 10.28 (6.11) | 9.18 (6.20) | |
| Mild symptoms (PHQ-9 ≥ 5–9), | 27 (36.5%) | 26 (35.1%) | 25 (33.8%) | |
| Prevalence of depression (PHQ-9 ≥ 10), | 36 (48.6%) | 36 (48.7%) | 30 (40.5%) | |
| GAD-7, | 11.04 (5.77) | 11.00 (5.36) | 9.81 (5.60) | |
| Mild symptoms (GAD-7 ≥ 5–9), | 28 (37.8%) | 25 (33.8%) | 30 (40.5%) | |
| Prevalence of anxiety (GAD-7 ≥ 10), | 37 (50.0%) | 42 (56.8%) | 33 (44.6%) | |
| MHC-SF (total score), | 29.82 (13.07) | 32.35 (15.26) | 31.73 (17.08) | |
| MHC-SF EW, | 7.04 (3.45) | 7.36 (3.54) | 7.24 (4.02) | |
| MHC-SF SW, | 7.85 (4.91) | 8.39 (5.96) | 8.57 (6.49) | |
| MHC-SF PW, | 14.93 (6.81) | 16.59 (7.22) | 15.92 (8.22) |
S-AII, self-affirming implementation intention condition; MGI, mere goal intention condition (control condition); BS-AII, body-related self-affirming implementation intention condition; SAPASI, Self-Administered Psoriasis Area and Severity Index (the range of absolute SAPASI scores is 0 – 72); PHQ-9, 9-item Patient Health Questionnaire; GAD-7, 7-item Generalized Anxiety Disorder Scale; MHC-SF, Mental Health Continuum–Short Form; EW, emotional well-being subscale; SW, social well-being subscale; PW, psychological well-being subscale.
Results of the LMM analyses for primary outcomes, omnibus tests for fixed effects.
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Time | 11.91 | 2 | 377 | <0.001 | 30.82 | 2 | 380 | <0.001 | 11.94 | 2 | 372 | <0.001 |
| Condition | 1.48 | 2 | 219 | 0.229 | 0.892 | 2 | 217 | 0.412 | 0.35 | 2 | 220 | 0.702 |
| Booster | 0.01 | 1 | 220 | 0.995 | 0.04 | 1 | 218 | 0.844 | 0.02 | 1 | 220 | 0.895 |
| Gender | 0.99 | 1 | 226 | 0.322 | 0.39 | 1 | 226 | 0.534 | 1.26 | 1 | 224 | 0.262 |
| Age | 1.49 | 1 | 217 | 0.224 | 1.86 | 1 | 215 | 0.174 | 0.11 | 1 | 218 | 0.740 |
| Time × condition | 0.12 | 4 | 377 | 0.978 | 1.41 | 4 | 380 | 0.230 | 0.19 | 4 | 372 | 0.942 |
| Time × booster | 0.23 | 2 | 377 | 0.791 | 1.08 | 2 | 380 | 0.341 | 1.53 | 2 | 372 | 0.219 |
| Condition × booster | 0.49 | 2 | 219 | 0.613 | 0.21 | 2 | 218 | 0.815 | 0.01 | 2 | 220 | 0.994 |
| Time × condition × booster | 0.73 | 4 | 377 | 0.574 | 0.15 | 4 | 380 | 0.965 | 1.50 | 4 | 372 | 0.200 |
| 0.04 | 0.07 | 0.02 | ||||||||||
| 0.66 | 0.58 | 0.77 | ||||||||||
df, degrees of freedom (Satterthwaite method for degrees of freedom).
Results of the LMM analyses for secondary outcomes, omnibus tests for fixed effects.
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Time | 24.30 | 2 | 375 | <0.001 | 21.05 | 2 | 374 | <0.001 | 0.28 | 2 | 378 | 0.754 |
| Condition | 0.55 | 2 | 222 | 0.577 | 0.18 | 2 | 218 | 0.840 | 0.69 | 2 | 219 | 0.502 |
| Booster | 0.90 | 1 | 222 | 0.343 | 0.16 | 1 | 218 | 0.688 | 0.10 | 1 | 219 | 0.754 |
| Gender | 0.20 | 1 | 226 | 0.657 | 1.52 | 1 | 223 | 0.219 | 9.38 | 1 | 226 | 0.002 |
| Age | 0.01 | 1 | 220 | 0.928 | 0.01 | 1 | 216 | 0.983 | 2.04 | 1 | 217 | 0.154 |
| Time × condition | 1.70 | 4 | 375 | 0.149 | 1.22 | 4 | 374 | 0.301 | 0.63 | 4 | 378 | 0.641 |
| Time × booster | 1.00 | 2 | 375 | 0.370 | 1.45 | 2 | 374 | 0.234 | 0.02 | 2 | 378 | 0.978 |
| Condition × booster | 0.37 | 2 | 222 | 0.694 | 0.36 | 2 | 218 | 0.702 | 2.50 | 2 | 219 | 0.085 |
| Time × condition × booster | 1.95 | 4 | 375 | 0.102 | 2.28 | 4 | 374 | 0.060 | 0.55 | 4 | 378 | 0.701 |
| 0.04 | 0.05 | 0.07 | ||||||||||
| 0.76 | 0.70 | 0.65 | ||||||||||
df, degrees of freedom (Satterthwaite method for degrees of freedom).
Age and self-esteem as moderators of the intervention effects.
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| ||||||||
| Interaction 1 | 0.05 (0.15) | 0.33 | 0.741 | −0.04 (0.15) | −0.26 | 0.794 | ||
| Interaction 2 | –0.38 (0.18) | –2.08 | 0.039 | −0.02 (0.19) | −0.10 | 0.922 | ||
|
| ||||||||
| Interaction 1 | 0.02 (0.15) | 0.12 | 0.903 | −0.13 (0.13) | −0.96 | 0.337 | ||
| Interaction 2 | 0.08 (0.18) | 0.43 | 0.668 | –0.35 (0.16) | –2.28 | 0.024 | ||
Interaction 1 – interaction between group (coded as MGI vs. S-AII, BS-AII) and moderator variable; Interaction 2 – interaction between group (coded as S-AII vs. BS-AII) and moderator variable; BS-AII, body-related self-affirming implementation intention; MGI, mere goal intention condition; S-AII, self-affirming implementation intention condition.
Figure 2Moderating effects of age between the group assignment and anxiety symptoms at post-intervention (T2). Both the x- and y-axis represent standardized values.
Conditional effects of the group at values of the tested moderators.
|
|
| ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
|
| ||||||
| MGI vs. S-AII, BS-AII | 0.10 (0.22) | 0.43 | 0.665 | MGI vs. S-AII, BS-AII | 0.13 (0.19) | 0.68 | 0.501 |
| S-AII vs. BS-AII | 0.06 (0.25) | 0.26 | 0.799 | S-AII vs. BS-AII | 0.22 (0.21) | 1.05 | 0.295 |
|
|
| ||||||
| MGI vs. S-AII, BS-AII | 0.15 (0.15) | 0.96 | 0.341 | MGI vs. S-AII, BS-AII | 0.01 (0.13) | 0.02 | 0.985 |
| S-AII vs. BS-AII | −0.32 (0.18) | −1.75 | 0.083 | S-AII vs. BS-AII | −0.13 (0.15) | −0.84 | 0.402 |
|
|
| ||||||
| MGI vs. S-AII, BS-AII | 0.20 (0.21) | 0.92 | 0.359 | MGI vs. S-AII, BS-AII | −0.13 (0.18) | −0.70 | 0.490 |
| S-AII vs. BS-AII | –0.70 (0.27) | –2.64 | 0.009 | S-AII vs. BS-AII | –0.48 (0.23) | –2.12 | 0.035 |
S-AII, self-affirming implementation intention condition; BS-AII, body-related self-affirming implementation intention; MGI, mere goal intention condition. Values of the moderator: high (one standard deviation above the mean), intermediate (at the mean), and low (one standard deviation below the mean).
Figure 3Moderating effects of self-esteem between the group assignment and negative emotional attitude toward the body at post-intervention (T2). Both the x- and y-axis represent standardized values.